Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTLCarina Lotz, Sarah Abdel Mutallib, Nicole Oehlrich, et al.
Scientific Reports|November 27, 2019
Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver diseaseMuhammad Ashfaq-Khan, Misbah Aslam, Muhammad Asif Qureshi, et al.
Immunity|January 25, 2005
Cooperation of human tumor-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCRJürgen Kuball, Frank W Schmitz, Ralf-Holger Voss, et al.
Biomaterials|September 12, 2016
Polymeric hepatitis C virus non-structural protein 5A nanocapsules induce intrahepatic antigen-specific immune responsesMichael Fichter, Keti Piradashvili, Anette Pietrzak-Nguyen, et al.
Archives of Toxicology|May 31, 2018
The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cellsNicole Kiweler, Boris Brill, Matthias Wirth, et al.
Oncogene|March 1, 2005
Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancerCarl C Schimanski, Gösta Schmitz, Anuba Kashyap, et al.
Nature Communications|January 26, 2020
Inhibition of histone deacetylation rescues phenotype in a mouse model of Birk-Barel intellectual disability syndromeAlexis Cooper, Tamer Butto, Niklas Hammer, et al.
Blood|August 23, 2019
Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosisNadine Müller-Calleja, Anne Hollerbach, Svenja Ritter, et al.
Cardiovascular Research|December 5, 2013
Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertensionDaniel Sollinger, Ruth Eißler, Steffen Lorenz, et al.
Hepatology (Baltimore, Md.)|March 26, 2013
Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patientsJens U Marquardt, Kerstin Fischer, Katharina Baus, et al.
Pageof 8